Home

L04AB04 Adalimumab -originator 40 mg/0,4 ml

Deadline:03 Aug 2025, 22:00 UTC

Tender information

TED EU

Skopje, North Macedonia

Type
16
Procedure
open
Ref. number
436471-2025
CPV
33600000

Biological therapy and Eltrombopag

Show all tender information

Documents

Show all important dates